324 related articles for article (PubMed ID: 35358491)
1. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England.
Mensah AA; Campbell H; Stowe J; Seghezzo G; Simmons R; Lacy J; Bukasa A; O'Boyle S; Ramsay ME; Brown K; Ladhani SN
Lancet Child Adolesc Health; 2022 Jun; 6(6):384-392. PubMed ID: 35358491
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.
Medic S; Anastassopoulou C; Lozanov-Crvenkovic Z; Dragnic N; Petrovic V; Ristic M; Pustahija T; Tsakris A; Ioannidis JPA
JAMA Netw Open; 2023 Feb; 6(2):e2255779. PubMed ID: 36780157
[TBL] [Abstract][Full Text] [Related]
4. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
Graham MS; Sudre CH; May A; Antonelli M; Murray B; Varsavsky T; Kläser K; Canas LS; Molteni E; Modat M; Drew DA; Nguyen LH; Polidori L; Selvachandran S; Hu C; Capdevila J; ; Hammers A; Chan AT; Wolf J; Spector TD; Steves CJ; Ourselin S
Lancet Public Health; 2021 May; 6(5):e335-e345. PubMed ID: 33857453
[TBL] [Abstract][Full Text] [Related]
5. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
Jeffery-Smith A; Rowland TAJ; Patel M; Whitaker H; Iyanger N; Williams SV; Giddings R; Thompson L; Zavala M; Aiano F; Ellis J; Lackenby A; Höschler K; Brown K; Ramsay ME; Gopal R; Chow JY; Ladhani SN; Zambon M
Lancet Healthy Longev; 2021 Dec; 2(12):e811-e819. PubMed ID: 34873592
[TBL] [Abstract][Full Text] [Related]
6. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
[TBL] [Abstract][Full Text] [Related]
7. Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England.
Forbes H; Morton CE; Bacon S; McDonald HI; Minassian C; Brown JP; Rentsch CT; Mathur R; Schultze A; DeVito NJ; MacKenna B; Hulme WJ; Croker R; Walker AJ; Williamson EJ; Bates C; Mehrkar A; Curtis HJ; Evans D; Wing K; Inglesby P; Drysdale H; Wong AYS; Cockburn J; McManus R; Parry J; Hester F; Harper S; Douglas IJ; Smeeth L; Evans SJW; Bhaskaran K; Eggo RM; Goldacre B; Tomlinson LA
BMJ; 2021 Mar; 372():n628. PubMed ID: 33737413
[TBL] [Abstract][Full Text] [Related]
8. Disease severity during SARS-COV-2 reinfection: a nationwide study.
Mensah AA; Lacy J; Stowe J; Seghezzo G; Sachdeva R; Simmons R; Bukasa A; O'Boyle S; Andrews N; Ramsay M; Campbell H; Brown K
J Infect; 2022 Apr; 84(4):542-550. PubMed ID: 35085659
[TBL] [Abstract][Full Text] [Related]
9. Milder outcomes of SARS-CoV-2 genetically confirmed reinfections compared to primary infections with the delta variant: A retrospective case-control study.
Suljič A; Sočan M; Mrzel M; Lunar MM; Korva M; Štorman A; Prosenc K; Janežič S; Žohar-Čretnik T; Zupanič T; Poljak M; Avšič-Županc T
Front Med (Lausanne); 2022; 9():962653. PubMed ID: 36275814
[TBL] [Abstract][Full Text] [Related]
10. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.
Twohig KA; Nyberg T; Zaidi A; Thelwall S; Sinnathamby MA; Aliabadi S; Seaman SR; Harris RJ; Hope R; Lopez-Bernal J; Gallagher E; Charlett A; De Angelis D; Presanis AM; Dabrera G;
Lancet Infect Dis; 2022 Jan; 22(1):35-42. PubMed ID: 34461056
[TBL] [Abstract][Full Text] [Related]
11. Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study.
Medić S; Anastassopoulou C; Lozanov-Crvenković Z; Vuković V; Dragnić N; Petrović V; Ristić M; Pustahija T; Gojković Z; Tsakris A; Ioannidis JPA
Lancet Reg Health Eur; 2022 Sep; 20():100453. PubMed ID: 35791336
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States.
Wang H; Wright T; Everhart K; Oyeniran SJ; Mejias A; Leber AL
J Pediatric Infect Dis Soc; 2023 Apr; 12(4):198-204. PubMed ID: 37004190
[TBL] [Abstract][Full Text] [Related]
13. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
[TBL] [Abstract][Full Text] [Related]
14. Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform.
Nab L; Parker EPK; Andrews CD; Hulme WJ; Fisher L; Morley J; Mehrkar A; MacKenna B; Inglesby P; Morton CE; Bacon SCJ; Hickman G; Evans D; Ward T; Smith RM; Davy S; Dillingham I; Maude S; Butler-Cole BFC; O'Dwyer T; Stables CL; Bridges L; Bates C; Cockburn J; Parry J; Hester F; Harper S; Zheng B; Williamson EJ; Eggo RM; Evans SJW; Goldacre B; Tomlinson LA; Walker AJ;
Lancet Public Health; 2023 May; 8(5):e364-e377. PubMed ID: 37120260
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.
Lacy J; Mensah A; Simmons R; Andrews N; Siddiqui MR; Bukasa A; O'Boyle S; Campbell H; Brown K
Epidemiol Infect; 2022 May; 150():e109. PubMed ID: 35607808
[TBL] [Abstract][Full Text] [Related]
16. Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua.
Kubale J; Balmaseda A; Frutos AM; Sanchez N; Plazaola M; Ojeda S; Saborio S; Lopez R; Barilla C; Vasquez G; Moreira H; Gajewski A; Campredon L; Maier HE; Chowdhury M; Cerpas C; Harris E; Kuan G; Gordon A
JAMA Netw Open; 2022 Jun; 5(6):e2218794. PubMed ID: 35759261
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador.
Guevara R; Prado-Vivar B; Márquez S; Muñoz EB; Carvajal M; Guadalupe JJ; Becerra-Wong M; Proaño S; Bayas-Rea R; Coloma J; Grunauer M; Trueba G; Rojas-Silva P; Barragán V; Cárdenas P
Front Cell Infect Microbiol; 2022; 12():951383. PubMed ID: 36164552
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 reinfections during the Delta and Omicron waves.
Morris CP; Eldesouki RE; Fall A; Gaston DC; Norton JM; Gallagher ND; Luo CH; Abdullah O; Klein EY; Mostafa HH
JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36048527
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 reinfections in Mexico City: implications for public health.
de Anda-Jáuregui G; Gómez-Romero L; Cañas S; Campos-Romero A; Alcántar-Fernández J; Cedro-Tanda A
Front Public Health; 2023; 11():1321283. PubMed ID: 38419814
[TBL] [Abstract][Full Text] [Related]
20. Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
Abu-Raddad LJ; Chemaitelly H; Ayoub HH; Coyle P; Malek JA; Ahmed AA; Mohamoud YA; Younuskunju S; Tang P; Al Kanaani Z; Al Kuwari E; Butt AA; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Nasrallah GK; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Al Khal A; Bertollini R
PLoS Med; 2021 Dec; 18(12):e1003879. PubMed ID: 34914711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
